Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Ovarian Neoplasms 6Colonic Neoplasms 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Rectal Neoplasms 1Peritoneal Neoplasms 1Pancreatitis, Acute Necrotizing 1Pancreatic Fistula 1Pancreatic Cyst 1Neoplasm Metastasis 1Melanoma 1Malignant Female Reproductive System Neoplasm 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Krukenberg Tumor 1Hyperthermia 1Fallopian Tube Neoplasms 1Eye Neoplasms 1Endometrial Neoplasms 1Complex Ovarian Cyst 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Burkitt Lymphoma 1Anastomotic Leak 1Abdominal Injuries 1Abdominal Abscess 1

Interventions

montanide ISA 51 2Interleukin-2 2Vincristine 1Topotecan 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Peptides 1MART-1 Antigen 1MAGEA3 protein, human 1Leuprolide 1Laparotomy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Eye Enucleation 1Etoposide 1Doxorubicin 1D-methadone 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Eye Neoplasms × Laparotomy × Clear all
NCT00062933 2012-08-20

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
40 enrolled
Dermatologic

Hyperthermia, Uveal Melanoma, Eye Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡